Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
7,236
Total Claims
$626K
Drug Cost
756
Beneficiaries
$828
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+71%
Opioid rate vs peers
70.6% vs 41.3% avg
+108%
Cost per patient vs peers
$828 vs $399 avg
+157%
Brand preference vs peers
9.6% vs 3.8% avg
Opioid Prescribing
70.6%
Opioid Rate
5,106
Opioid Claims
$436K
Opioid Cost
30.8%
Long-Acting Rate
This provider's opioid prescribing rate of 70.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 698 claims · $362K
Generic: 6,538 claims · $264K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 222 | $161K |
| Oxycodone Hcl | 102 | $65K |
| Oxycodone Hcl/Acetaminophen | 1,005 | $48K |
| Methylnaltrexone Bromide | 19 | $47K |
| Oxycodone Hcl | 1,267 | $45K |
| Morphine Sulfate | 846 | $27K |
| Fentanyl | 201 | $25K |
| Hydrocodone/Acetaminophen | 677 | $23K |
| Linaclotide | 34 | $19K |
| Chlorzoxazone | 12 | $18K |
| Pregabalin | 310 | $15K |
| Buprenorphine Hcl | 12 | $11K |
| Hydromorphone Hcl | 329 | $10K |
| Naloxegol Oxalate | 25 | $9,919 |
| Gabapentin | 388 | $7,297 |
Prescribing Profile
40
Unique Drugs
17.0
Anomaly Score
Patient Profile
66
Avg Age
57%
Female
2.17
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About